Newsbenzinga
Haemonetics Stock Hits 52-Week High - Here's Why
· Published
Article summary
Haemonetics stock hits a new 52-week high after CSL Plasma outlines a sweeping rollout of its technology across existing U.S. centers.
An excerpt from the original article.
Comments —
Loading comments…